RBC Capital analyst Luca Issi maintained a Buy rating on RegenXBio (RGNX – Research Report) today and set a price target of $30.00. The ...

RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to ...

Morgan Stanley analyst Robert Koh maintained a Buy rating on AGL Energy Limited (AGLNF – Research Report) today and set a price target of ...

RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on ...

RBC Capital Markets analyst Maurice Choy identifies relative “safer havens” in the yield-heavy energy infrastructure sector, ...

T-Mobile Us Inc (TMUS) stock saw a modest uptick, ending the day at $218.97 which represents a slight increase of $3.22 or 1.49% from the prior close of $215.75. The stock opened at $219.21 and ...

Dyne Therapeutics Inc (DYN) stock saw a decline, ending the day at $14.13 which represents a decrease of $-0.64 or -4.33% from the prior close of $14.77. The stock opened at $14.89 and touched a low ...

On Thursday, RBC Capital Markets adjusted its outlook on shares of JPMorgan Chase & Co. (NYSE: NYSE:JPM) shares by increasing the price target to $260 from the previous $248, while retaining an ...

In his latest memo named “On Bubble Watch,” Howard Marks, co-founder and co-chairman of Oaktree Capital ... the optimism that has prevailed in the markets since late 2022, the above average ...

Hedge funds have positioned for Donald Trump's U.S. presidency with their highest levels of borrowing since 2010, while ...

On Thursday, RBC Capital Markets adjusted its outlook on shares of JPMorgan Chase & Co. (NYSE: NYSE:JPM) shares by increasing the price target to $260 from the previous $248, while retaining an ...

Daniel Fannon; Analyst; Jefferies & Company Inc. Gerard Cassidy; Analyst; RBC Capital Markets ...